DK1782068T3 - Overvågning af hjertesvigt - Google Patents

Overvågning af hjertesvigt

Info

Publication number
DK1782068T3
DK1782068T3 DK04763439.9T DK04763439T DK1782068T3 DK 1782068 T3 DK1782068 T3 DK 1782068T3 DK 04763439 T DK04763439 T DK 04763439T DK 1782068 T3 DK1782068 T3 DK 1782068T3
Authority
DK
Denmark
Prior art keywords
heart failure
myocardial infarction
suffered
subject
concentration
Prior art date
Application number
DK04763439.9T
Other languages
English (en)
Inventor
Daniel Wagner
Original Assignee
Ct De Rech Public De La Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct De Rech Public De La Sante filed Critical Ct De Rech Public De La Sante
Application granted granted Critical
Publication of DK1782068T3 publication Critical patent/DK1782068T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Gyroscopes (AREA)
  • Eye Examination Apparatus (AREA)
  • Paper (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • External Artificial Organs (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
DK04763439.9T 2004-07-23 2004-07-23 Overvågning af hjertesvigt DK1782068T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2004/008259 WO2006007869A1 (en) 2004-07-23 2004-07-23 Monitoring heart failure

Publications (1)

Publication Number Publication Date
DK1782068T3 true DK1782068T3 (da) 2010-08-02

Family

ID=34958367

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04763439.9T DK1782068T3 (da) 2004-07-23 2004-07-23 Overvågning af hjertesvigt

Country Status (8)

Country Link
US (1) US7319017B2 (da)
EP (1) EP1782068B1 (da)
AT (1) ATE463743T1 (da)
DE (1) DE602004026488D1 (da)
DK (1) DK1782068T3 (da)
ES (1) ES2342394T3 (da)
PL (1) PL1782068T3 (da)
WO (1) WO2006007869A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101431B2 (en) * 2004-02-27 2012-01-24 Board Of Regents, The University Of Texas System Integration of fluids and reagents into self-contained cartridges containing sensor elements and reagent delivery systems
US8377398B2 (en) 2005-05-31 2013-02-19 The Board Of Regents Of The University Of Texas System Methods and compositions related to determination and use of white blood cell counts
AU2006261953B2 (en) * 2005-06-24 2012-02-23 Board Of Regents, The University Of Texas System Systems and methods including self-contained cartridges with detection systems and fluid delivery systems
WO2007005666A2 (en) * 2005-07-01 2007-01-11 Board Of Regents, The University Of Texas System System and method of analyte detection using differential receptors
KR20090046825A (ko) * 2006-07-11 2009-05-11 무스크 파운데이션 포 리서치 디벨롭먼트 프로테아제 및 프로테아제 저해제 프로파일링으로 심근 경색 후 심부전을 예측하는 방법
CA2697357A1 (en) * 2007-04-16 2008-10-30 John T. Mcdevitt Cardibioindex/cardibioscore and utility of salivary proteome in cardiovascular diagnostics
WO2011153127A1 (en) 2010-06-01 2011-12-08 Cardiac Pacemakers, Inc. Integrating sensors and biomarker assays to detect worsening heart failure
US10368774B2 (en) 2015-07-30 2019-08-06 Medtronic, Inc. Absolute intrathoracic impedance based scheme to stratify patients for risk of a heart failure event

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9607287D0 (en) * 1996-04-09 1996-06-12 British Biotech Pharm Diagnosis method
AUPO573697A0 (en) * 1997-03-20 1997-04-10 Prince Henry's Institute Of Medical Research Diagnosis of endometrial cancer
EP1038178A1 (en) * 1998-10-08 2000-09-27 Calbiochem Novabiochem Corporation Diagnostic assay for matrix metalloproteinase 9 and use thereof
DE60217102T2 (de) 2001-05-04 2007-06-28 Ischemia Technologies, Inc., Waltham Verbesserungen der diagnose des akuten myokardinfarkts und anderer klinischer zustände

Also Published As

Publication number Publication date
ES2342394T3 (es) 2010-07-06
US7319017B2 (en) 2008-01-15
US20060029993A1 (en) 2006-02-09
PL1782068T3 (pl) 2010-09-30
EP1782068B1 (en) 2010-04-07
WO2006007869A1 (en) 2006-01-26
ATE463743T1 (de) 2010-04-15
EP1782068A1 (en) 2007-05-09
DE602004026488D1 (de) 2010-05-20

Similar Documents

Publication Publication Date Title
Kind et al. Verbal and physical client aggression–A longitudinal analysis of professional caregivers’ psychophysiological stress response and burnout
Ergun et al. Evaluation of oxidative stress and antioxidant profile in patients with oral lichen planus
MXPA02007421A (es) Dispositivos para determinacion de concentracion de analitos y metodos para utilizar los mismos.
WO2007044860A3 (en) Diabetes-associated markers and methods of use thereof
Visalli et al. Genotoxic damage in the oral mucosa cells of subjects carrying restorative dental fillings
DK1053043T3 (da) Opsamlingsenheder til transdermale prøveudtagningssystemer
MX351004B (es) Ensayos para diagnosticar y evaluar opciones de tratamiento para enfermedad de fabry.
GB0524110D0 (en) Biomarkers and methods for identification of agents useful in the treatment of affective disorders
DK1782068T3 (da) Overvågning af hjertesvigt
Choi et al. Inter‐relationships between DNA damage, ascorbic acid and glycaemic control in Type 2 diabetes mellitus
DE602005023009D1 (de) Verfahren in echtzeit zur erkennung von akuten entzündungszuständen
Karavelioglu et al. Blood pressure response to exercise is exaggerated in normotensive diabetic patients
Kulkarni et al. Urinary C-Peptide and urine C-pentide/Creatinine ratio (UCPCR) are possible predictors of endogenous insulin secretion in T2DM subjects-a randomized study.
MX2009001070A (es) Uso de proteina con actividad inhibidora de melanoma (mia) como un indicador temprano para la respuesta terapeutica en melanoma.
Lefkowitz et al. Intraindividual stability of human erythrocyte cholinesterase activity
Zhu et al. Simultaneous in vivo optical quantification of key metabolic and vascular endpoints reveals tumor metabolic diversity in murine breast tumor models
Björkman et al. Calculated serum calcium is an insufficient surrogate for measured ionized calcium
Thongsringklee et al. Health effects of low level exposure to lead among communication radio repair workers at Samutsakhon province, Thailand
Arora et al. Oxidative stress and its relation to glycemic control in patients of type 2 diabetes mellitus
Pencina et al. Objectively measured physical activity in asymptomatic middle-aged men is associated with routine blood-based biomarkers
Awadallah et al. Association of haptoglobin phenotypes with markers of diabetic nephropathy in type 2 diabetes mellitus
BR0209681A (pt) Método e kit para o diagnóstico in vivo ou para o monitoramento de uma doença que envolve uma reação inflamatória dentro de um paciente
Gachoki Comparative analysis of random blood glucose levels in serum, plasma and whole blood using glucose oxidase and hexokinase methods under spectrophotometric and electrochemical techniques
Raghavani et al. Renal function impairment and HbA1c level in type 2 diabetes mellitus patients
ATE261120T1 (de) Anhand der konduktivität normalisierte bestimmung von analyten in urin zur diagnose von krankheiten